Inventor · disambiguated record
Maxime C. Soumeillant
Also filed as: SOUMEILLANT MAXIME · SOUMEILLANT MAXIME C · SOUMEILLANT MAXIME C D
10 granted patents·2 pending applications·11 citations·filing 2013–2022
84Inventor score
Top patents by PatentIndex Score
12 records- 0189US8889869B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 18, 2014·5 cites·8 claims
- 0286US9249168B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 2, 2016·3 cites·2 claims
- 0379US9255113B2Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 9, 2016·1 cites·3 claims
- 0478US9243010B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 26, 2016·1 cites·4 claims
- 0575US11649226B2Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl- D3)pyridazine-3-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2020·Granted May 16, 2023·1 cites·2 claims
- 0670US9394322B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 19, 2016·0 cites·3 claims
- 0769US9403821B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 2, 2016·0 cites·4 claims
- 0869US9376458B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 28, 2016·0 cites·2 claims
- 0962US2016152644A1Methods for the preparation of hiv attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 1062US2022177482A1Process for the preparation of n-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamideBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1149US11254679B2Process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamideBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 22, 2022·0 cites·1 claims
- 1232US10221208B2Methods of producing an HIV maturation inhibitorVIIV HEALTHCARE UK NO 4 LTD·Filed 2016·Granted Mar 5, 2019·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →